These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 17067573

  • 1. SDF-1-induced adhesion of monocytes to vascular endothelium is modulated by azelnidipine via protein kinase C inhibition.
    Takahashi K, Shimokado K, Yoshida M.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):162-9. PubMed ID: 17067573
    [Abstract] [Full Text] [Related]

  • 2. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
    Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M.
    Life Sci; 2004 Jul 30; 75(11):1333-41. PubMed ID: 15234191
    [Abstract] [Full Text] [Related]

  • 3. Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist.
    Nakamura K, Yamagishi S, Inoue H.
    Med Hypotheses; 2005 Jul 30; 65(1):155-7. PubMed ID: 15893134
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells.
    Ma J, Kishida S, Wang GQ, Meguro K, Imuta H, Oonuma H, Iida H, Jo T, Takano H, Morita T, Nagai R, Nakajima T.
    J Cardiovasc Pharmacol; 2006 Feb 30; 47(2):314-21. PubMed ID: 16495772
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibitor attenuates monocyte adhesion to vascular endothelium through modulation of intracellular zinc.
    Kojima C, Kawakami A, Takei T, Nitta K, Yoshida M.
    J Pharmacol Exp Ther; 2007 Dec 30; 323(3):855-60. PubMed ID: 17878405
    [Abstract] [Full Text] [Related]

  • 6. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
    Zhang H, Issekutz AC.
    Am J Pathol; 2002 Jun 30; 160(6):2219-30. PubMed ID: 12057924
    [Abstract] [Full Text] [Related]

  • 7. Antioxidative effects of azelnidipine on mesangial cell proliferation induced by highly concentrated insulin.
    Manabe S, Okura T, Fukuoka T, Higaki J.
    Eur J Pharmacol; 2007 Jul 19; 567(3):252-7. PubMed ID: 17544393
    [Abstract] [Full Text] [Related]

  • 8. Effects of benidipine, a dihydropyridine-Ca2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells.
    Matsubara M, Hasegawa K.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):303-14. PubMed ID: 15364009
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species.
    Naito Y, Shimozawa M, Manabe H, Nakabe N, Katada K, Kokura S, Yoshida N, Ichikawa H, Kon T, Yoshikawa T.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):11-8. PubMed ID: 16919261
    [Abstract] [Full Text] [Related]

  • 11. Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion.
    Hung CF, Huang TF, Chen BH, Shieh JM, Wu PH, Wu WB.
    Eur J Pharmacol; 2008 May 31; 586(1-3):275-82. PubMed ID: 18439578
    [Abstract] [Full Text] [Related]

  • 12. Amlodipine modulates THP-1 cell adhesion to vascular endothelium via inhibition of protein kinase C signal transduction.
    Yu T, Morita I, Shimokado K, Iwai T, Yoshida M.
    Hypertension; 2003 Sep 31; 42(3):329-34. PubMed ID: 12900427
    [Abstract] [Full Text] [Related]

  • 13. Cxc chemokine receptor expression on human endothelial cells.
    Murdoch C, Monk PN, Finn A.
    Cytokine; 1999 Sep 31; 11(9):704-12. PubMed ID: 10479407
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells.
    Matsui T, Yamagishi S, Nakamura K, Kikuchi S, Inoue H.
    Drugs Exp Clin Res; 2005 Sep 31; 31(5-6):215-9. PubMed ID: 16425978
    [Abstract] [Full Text] [Related]

  • 17. Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-alpha-induced monocyte chemoattractant protein-1 expression in endothelial cells.
    Matsui T, Yamagishi S, Nakamura K, Inoue H.
    J Int Med Res; 2006 Sep 31; 34(6):671-5. PubMed ID: 17295000
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells.
    Hojo Y, Ikeda U, Takahashi M, Sakata Y, Takizawa T, Okada K, Saito T, Shimada K.
    J Mol Cell Cardiol; 2000 Aug 31; 32(8):1459-68. PubMed ID: 10900172
    [Abstract] [Full Text] [Related]

  • 19. Attenuation of monocyte adhesion and oxidised LDL uptake in luteolin-treated human endothelial cells exposed to oxidised LDL.
    Jeong YJ, Choi YJ, Choi JS, Kwon HM, Kang SW, Bae JY, Lee SS, Kang JS, Han SJ, Kang YH.
    Br J Nutr; 2007 Mar 31; 97(3):447-57. PubMed ID: 17313705
    [Abstract] [Full Text] [Related]

  • 20. Effect of Benincasa hispida Cogniaux on high glucose-induced vascular inflammation of human umbilical vein endothelial cells.
    Moon MK, Kang DG, Lee YJ, Kim JS, Lee HS.
    Vascul Pharmacol; 2009 Mar 31; 50(3-4):116-22. PubMed ID: 19063994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.